Aldagen gains $17.3M in third round
VENTURE CAPITAL |
|||
COMPANY |
AMOUNT/ROUND |
LEAD INVESTORS |
DESCRIPTION |
Aldagen
|
$17.3M
|
Harbert Venture Partners and Intersouth Partners |
The company will use these funds to advance its pipeline of regenerative medicine clinical studies. |